Stroke 2024 | Dublin | Ireland | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Advancing Neurological Care: Bridging Innovations and Insights for Stroke and Neurological Disorders

- Stroke 2024

Welcome Message

Esteemed guests, and distinguished participants,

It is our great pleasure to extend a warm welcome to each one of you as we gather for the “13th International Conference on neurological disorders and stroke,” scheduled to take place in the vibrant city of Dublin, Ireland, on June 20-21, 2024.

Our conference theme, "Advancing Neurological Care: Bridging Innovations and Insights for stroke and neurological disorders," underscores the critical need for collaboration, innovation, and a shared commitment to enhancing the care and understanding of neurological health. Dublin, with its rich history and contemporary spirit, provides an inspiring backdrop for this important gathering.

Over the course of the next two days, we are privileged to host distinguished experts, researchers, and practitioners from around the globe who will share their cutting-edge insights and discoveries. This conference serves as a platform for fostering interdisciplinary discussions, forging collaborations, and advancing our collective knowledge in the realm of neurological disorders and stroke.

I encourage you to actively engage in the sessions, exchange ideas, and contribute to the dialogue that will undoubtedly shape the future of neurological care. Together, let us explore innovative approaches, bridge gaps in understanding, and ultimately strive towards improving the lives of those affected by neurological disorders and stroke.

Once again, a heartfelt welcome to Dublin, and I wish everyone a productive and enriching experience at the 13th International Conference on neurological disorders and stroke.

Thank you.

About Conference

Every year, Allied Academies organizes interdisciplinary international conferences worldwide, focusing on cutting-edge basic and applied research in life sciences, pharmaceuticals, medicine, healthcare, and nursing. These conferences feature presentations by leading talents in both industry and academia, offering a platform for the scientific community to access the latest technical and scientific achievements.

Our conferences are designed to drive progress in the scientific community, fostering the exchange of ideas and facilitating access to groundbreaking research findings. Allied Academies has emerged as a prominent choice for experts and academicians to showcase their remarkable contributions. As a publisher, we provide a comprehensive platform for readers and authors to share their work with a global audience.

The objective of Allied Academies Conferences is to bring together researchers, principal investigators, experts, and professionals from academia and the healthcare industry, along with business delegates, scientists, and students worldwide. These conferences serve as an international forum for the dissemination of original research results, the discussion of new ideas, and the sharing of practical development experiences.

Our academic events aim to reinvigorate enduring connections and foster new collaborations on a global scale. By providing a platform for global experts and speakers, Allied Academies Conferences facilitate discussions on advancements in medical and engineering fields, with a focus on enhancing e-health, treatment methodologies, and other innovations. The conferences not only serve as a forum for exchanging insights with a large audience but also strive to disseminate focused and research-driven advances in clinical and physiological aspects across various fields.

List of Sessions

Stroke Prevention and Treatment
Neurodegenerative Disorders
Epilepsy and Seizure Disorders
Neuroimaging and Diagnostic Techniques
Pediatric Neurology
Neuroimmunology and Multiple Sclerosis
Neurocritical Care and Emergency Neurology
Neurogenetics and Genomic Medicine
Neuro-oncology
Cerebrovascular Disorders
Movement Disorders
Neuroethics and Societal Impact
Rehabilitation and Recovery
Emergency Medical Services (EMS) and Prehospital Stroke Care
Acute Stroke Management

Market Analysis

The Neurological Disorders and Stroke market is witnessing robust growth attributed to a combination of factors influencing the prevalence of neurological conditions and Strokes globally. The market encompasses pharmaceuticals, medical devices, and therapeutic interventions targeting Neurological Disorders and Stroke prevention and treatment.

The increasing aging population, coupled with lifestyle-related risk factors, contributes to the rising incidence of Neurological Disorders and Strokes. This demographic trend, along with growing awareness about these conditions, propels the demand for effective treatment options. Pharmaceutical advancements, including neuroprotective drugs, anti-epileptics, and novel therapies for neurodegenerative diseases, contribute significantly to market expansion.

In the realm of Stroke treatment, there is a notable surge in the adoption of innovative medical devices such as clot retrieval devices for thrombectomy and neurointerventional devices. Additionally, the emphasis on preventive measures, including anticoagulants and antiplatelet drugs, augments the market.

Geographically, North America and Europe dominate the Neurological Disorders and Stroke market due to well-established healthcare infrastructure, high healthcare expenditure, and a large patient pool. However, the Asia-Pacific region is witnessing rapid market growth, driven by increasing healthcare awareness, rising disposable income, and a growing prevalence of Neurological Disorders.

Market competition is intense, with key players investing in research and development activities, strategic collaborations, and mergers and acquisitions to enhance their product portfolios and market presence. The integration of technology, personalized medicine approaches, and telemedicine solutions further shape the evolving landscape of the Neurological Disorders and Stroke market, reflecting a dynamic and innovative industry striving to meet the evolving healthcare needs globally.

Past Conference

On December 4, 2023, the 12th International Conference on Neurological Disorders and Stroke achieved resounding success in Dubai, UAE. The diverse and international assembly at Stroke 2023, representing the expansive field of neurology and Neurological Diseases, significantly contributed to the event's triumph. Concurrently, the 12th International Conference on Psychiatry and mental health was held alongside Stroke 2023 in Dubai during the same dates, enriching the conference experience.

Professionals from across the globe, specializing in Stroke, mental health, neurology, neuroscience, and related fields, participated in this global gathering. The attendees engaged in valuable networking opportunities, fostering connections among individuals working in diverse areas of expertise.

The conference's thematic focus on "Innovations in Diagnostics, Treatments, and Rehabilitation of Neurological Diseases and Stroke" reverberated powerfully, reflecting the industry's commitment to advancing patient care and outcomes.

The success of Stroke 2023 is indebted to the dedication and efforts of the organizing committee, led by Professor W S El MasrI from the Robert Jones & Agnes Hunt Orthopaedic Hospital Oswestry, UK, along with other committee members and on-site coordinators. Their commitment ensured the seamless execution of the conference and the fulfillment of its objectives.

In summary, the conference not only provided a platform for the exchange of cutting-edge knowledge but also facilitated meaningful connections among professionals working towards advancements in neurology, Neurological Diseases, Psychiatry, and mental health. Stroke 2023 expressed gratitude to all contributors for making the event a memorable and impactful success.

The following keynote speeches and some of the physical speakers elevated the conference:

Eva María González Díaz | Interventional Neuro Radiologist | Cruces University Hospital
Laura Lon | American Psychological Association | Romania
Sukumar Shanmugam | Gulf Medical University | UAE
Tawfiq Yousef Tawfiq Zyoud | University Putra Malaysia | Malaysia
Meruna Bose| Gulf Medical University | UAE
Jiangfan Chen | Wenzhou Medical University | China
Payal Maheshwari | College of Home Science Nirmala Niketan | India
Abdallah Elgabry | Central and North West London NHS Foundation Trust | UK
Akihiro Nishio | Okinawa Institute of Science and Technology | Japan
Anastasiia Iliukhina | Taurida National University | Ukraine
Giabelle Flecila Aguiling-Saldaña | University of the Philippines Visayas | Philippines
Isaac Daramola | Brevity Clinic | Australia
Shaista Anjum | Gulf Medical University | UAE
Nigar Abdullayeva | University of Calgary | Canada

Stroke 2023 extends its appreciation to all the organizing committee members, with special acknowledgment to Jiangfan Chen, Payal Maheshwari, Ariyo Shahin Jafari, Laura Ion, and Malini Narayanan, who served as the chairs and co-chairs for the Stroke 2023, Psychiatry, and mental health conferences.

https://Stroke.alliedacademies.com/ provides further information on the previous event.

Sessions & Tracks

Stroke Prevention and Treatment

The stroke Prevention and Treatment market is witnessing significant growth due to an increasing global burden of stroke cases. Market analysis indicates a rising demand for preventive measures and effective treatments, driven by a growing aging population and lifestyle-related risk factors. Innovations in pharmaceuticals, medical devices, and interventional procedures contribute to market expansion. Anticoagulants, antiplatelet drugs, and novel interventions such as thrombectomy devices are gaining prominence. Additionally, heightened awareness campaigns and government initiatives further fuel market growth. Geographically, North America and Europe hold substantial market shares, but the Asia-Pacific region is emerging as a lucrative market due to increasing healthcare infrastructure and rising stroke incidences. The market is competitive, with key players focusing on research and development, strategic collaborations, and product launches to maintain a competitive edge.

Innovations in Preventive Strategies
Advancements in Medical Interventions
Rehabilitation and Recovery Techniques

Related conferences:

Related associations:

Related Societies:

Related Journals:

Neurodegenerative Disorders

The Neurodegenerative Disorders market is experiencing significant growth, driven by an aging global population and an increasing prevalence of conditions such as Alzheimer's, Parkinson's, and Huntington's diseases. The demand for effective therapeutic interventions, including disease-modifying drugs and innovative treatments, is escalating. Pharmaceutical companies are actively engaged in research and development to address the unmet medical needs in this sector. Additionally, advancements in biomarker identification and diagnostic tools contribute to early detection and intervention. The market also witnesses a surge in strategic collaborations and partnerships to accelerate drug development. Geographically, North America and Europe hold substantial market shares, attributed to robust healthcare infrastructure and research investments. However, the Asia-Pacific region is emerging as a lucrative market, fueled by growing healthcare awareness and rising neurodegenerative disorder cases. Overall, the Neurodegenerative Disorders market is dynamic, characterized by ongoing research endeavors and a focus on delivering improved therapeutic outcomes.

Biomarkers and Early Detection
Therapeutic Innovations and Drug Development
Precision Medicine and Personalized Treatment Approaches

Related conferences:

Related associations:

Related Societies:

Related Journals:

Epilepsy and Seizure Disorders

Epilepsy and Seizure Disorders represent a spectrum of neurological conditions characterized by recurrent, unpredictable seizures affecting millions worldwide. Epileptic seizures result from abnormal electrical activity in the brain, leading to various manifestations, from brief lapses in awareness to convulsions. The causes range from genetic factors to brain injuries, infections, or tumors. Effective management often involves antiepileptic medications, lifestyle adjustments, and, in some cases, surgical interventions. Despite treatment options, a significant proportion of individuals with Epilepsy may face challenges in daily life, impacting their quality of life. Ongoing research aims to uncover new therapies, improve seizure prediction, and enhance overall understanding of these disorders. Education and awareness play crucial roles in dispelling myths and reducing the social stigma associated with Epilepsy, fostering a supportive environment for affected individuals.

Antiepileptic Medications and Treatment Strategies
Neurostimulation and Surgical Interventions
Comorbidities and Quality of Life

Related conferences:

Related associations:

Related Societies:

Related Journals:

Neuroimaging and Diagnostic Techniques

The Neuroimaging and Diagnostic Techniques market is experiencing substantial growth, propelled by technological advancements and a growing demand for precise and early diagnosis of neurological Disorders. Innovations in imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and functional MRI contribute to enhanced diagnostic accuracy. The market also benefits from the integration of artificial intelligence and machine learning algorithms, streamlining image analysis and interpretation. Rising incidences of neurological Disorders, coupled with a global aging population, drive market expansion. Geographically, North America and Europe dominate, attributed to well-established healthcare infrastructures. However, the Asia-Pacific region is witnessing rapid growth due to increasing healthcare investments and awareness. The market is characterized by competitive strategies, including mergers, acquisitions, and collaborations among key industry players, aiming to further advance diagnostic capabilities and broaden the scope of Neuroimaging technologies.

Advanced Imaging Modalities
Artificial Intelligence in Neurodiagnostics
Diagnostic Biomarkers and Molecular Imaging

Related conferences:

Related associations:

Related Societies:

Related Journals:

Pediatric Neurology

The Pediatric Neurology market is witnessing substantial growth as a result of increasing awareness, early diagnosis, and advancements in pediatric neurological care. The market encompasses a spectrum of disorders, including Epilepsy, neurogenetic disorders, and developmental delays in children. Rising instances of pediatric neurological conditions, coupled with a growing emphasis on specialized healthcare for children, drive market expansion. Technological innovations in diagnostic tools and treatment modalities contribute to improved patient outcomes. Additionally, collaborative efforts between healthcare providers, researchers, and pharmaceutical companies foster research and development in pediatric Neurology. Geographically, North America and Europe dominate the market, given their robust healthcare infrastructures. However, the Asia-Pacific region is experiencing notable growth, attributed to increasing healthcare investments and a rising prevalence of pediatric neurological Disorders. The market is characterized by ongoing research initiatives, with a focus on developing targeted therapies tailored to the unique needs of pediatric patients.

Childhood Epilepsy and Seizure Disorders
Neurogenetic Disorders in Pediatrics
Developmental and Behavioral Pediatrics

Related conferences:

Related associations:

Related Societies:

Related Journals:

Neuroimmunology and Multiple Sclerosis

The Neuroimmunology and Multiple Sclerosis market are experiencing significant growth due to increasing research focus, advanced treatment options, and rising incidences of autoimmune neurological Disorders. The market encompasses therapies, disease-modifying drugs, and diagnostic tools targeting neuroimmunological conditions, particularly Multiple Sclerosis (MS). Advances in understanding the immune system's role in neurological Disorders drive the development of novel treatments, including monoclonal antibodies and immunomodulatory drugs. The global prevalence of MS and the demand for effective therapies contribute to market expansion. Geographically, North America and Europe lead, supported by established healthcare infrastructures. The Asia-Pacific region is emerging as a key market, driven by improving healthcare awareness and diagnostic capabilities. The market is characterized by strategic collaborations, research partnerships, and ongoing clinical trials, reflecting a dynamic landscape with a focus on advancing treatments for neuroimmunological disorders.

Immunopathogenesis of Multiple Sclerosis
Emerging Therapies for Multiple Sclerosis
Precision Medicine in Neuroimmunology

Related conferences:

Related associations:

Related Societies:

Related Journals:

Neurocritical Care and Emergency Neurology

The Neurocritical Care and Emergency Neurology market are experiencing notable growth, driven by an increasing emphasis on specialized care for acute neurological conditions. The market encompasses a range of interventions, diagnostic tools, and therapeutic measures aimed at managing critical neurological emergencies. Advances in Neuroimaging, telemedicine, and rapid diagnostic technologies contribute to improved emergency response and patient outcomes. Rising incidences of strokes, traumatic brain injuries, and other acute neurological events fuel market expansion. Geographically, North America and Europe lead, owing to well-established healthcare infrastructures. The Asia-Pacific region is witnessing significant growth, attributed to increasing healthcare investments and awareness. The market is characterized by collaborations, research initiatives, and technological innovations, reflecting a dynamic landscape focused on enhancing emergency Neurology care globally.

Acute stroke Management in Emergency Neurology
Traumatic Brain Injury (TBI) and Neurotrauma Care
telemedicine and Remote neurological Emergency Care

Related conferences:

Related associations:

Related Societies:

Related Journals:

Neurogenetics and Genomic Medicine

The Neurogenetics and Genomic Medicine market is experiencing significant growth due to advancements in genomic technologies, increased understanding of genetic contributions to neurological Disorders, and the rising demand for personalized medicine. This market encompasses genetic testing services, next-generation sequencing platforms, and therapies tailored to individual genetic profiles. Growing awareness of the genetic basis of neurological conditions, such as neurodegenerative disorders and Epilepsy, fuels market expansion. Collaborations between genomics researchers, healthcare providers, and pharmaceutical companies contribute to ongoing research initiatives. North America and Europe lead the market, driven by robust healthcare infrastructures and research investments. The Asia-Pacific region shows promise with rising healthcare awareness and initiatives. The market is characterized by continuous technological innovation, precision medicine initiatives, and a focus on deciphering the genetic underpinnings of various neurological Disorders.

Genetic Basis of neurological Disorders
Precision Medicine in Neurogenetics
Emerging Technologies in Neurogenomic Research

Related conferences:

Related associations:

Related Societies:

Related Journals:

Neuro-oncology

The Neuro-oncology market is experiencing significant growth due to the increasing incidence of brain and Spinal Cord tumors, coupled with advancements in diagnostic technologies and treatment modalities. The market encompasses a range of therapeutic interventions, including surgery, radiation therapy, chemotherapy, and immunotherapy, aimed at treating primary and metastatic tumors of the central nervous system. Technological innovations, such as precision medicine approaches and targeted therapies, contribute to personalized treatment strategies. The rising demand for novel and effective treatments, coupled with ongoing research and development initiatives, drives market expansion. Geographically, North America and Europe dominate the market, given their advanced healthcare infrastructure. However, the Asia-Pacific region is emerging as a key market, driven by a growing awareness of neuro-oncological conditions and increasing healthcare investments. The market is characterized by collaborations, mergers, and acquisitions among key industry players to enhance treatment options and improve patient outcomes.

Brain Tumor Diagnosis and Imaging Techniques
Innovations in Neuro-Oncological Treatments
Biomarkers and Molecular Profiling in Neuro-oncology

Related conferences:

Related associations:

Related Societies:

Related Journals:

Cerebrovascular Disorders

The Cerebrovascular Disorders market is witnessing significant growth driven by a rising incidence of stroke and other cerebrovascular conditions worldwide. The market encompasses pharmaceuticals, medical devices, and diagnostic technologies aimed at prevention, treatment, and management. With an aging global population and lifestyle-related risk factors, there is an increased demand for innovative therapeutic interventions, such as anticoagulants, antiplatelet drugs, and neurointerventional devices. Diagnostic advancements, including Neuroimaging and biomarker identification, further contribute to early detection and intervention. Geographically, North America and Europe are prominent markets due to well-established healthcare infrastructures, while the Asia-Pacific region exhibits substantial growth potential. The market is characterized by ongoing research and development, strategic collaborations, and a focus on delivering comprehensive and efficient solutions for cerebrovascular disorders.

Ischemic stroke: Mechanisms and Therapeutic Strategies
Hemorrhagic stroke: Causes and Surgical Interventions
Vascular Cognitive Impairment and Small Vessel Disease

Related conferences:

Related associations:

Related Societies:

Related Journals:

Movement Disorders

The Movement Disorders market is witnessing significant growth, driven by an increasing prevalence of disorders such as Parkinson's disease and essential tremor. Rising awareness, coupled with advancements in diagnostic technologies, contributes to early detection and intervention. Pharmaceutical companies are actively engaged in developing innovative therapies to address motor symptoms and improve the quality of life for affected individuals. Deep brain stimulation and other neuromodulation techniques are gaining prominence as effective treatment options. Additionally, collaborative research efforts and strategic partnerships are shaping the landscape of therapeutic interventions. Geographically, North America holds a substantial market share, attributed to a higher prevalence of movement disorders and well-established healthcare infrastructure. However, the Asia-Pacific region is emerging as a key market, driven by a growing aging population and increasing healthcare investments. Overall, the Movement Disorders market reflects dynamic advancements in diagnosis and treatment modalities.

Deep Brain Stimulation (DBS) in Movement Disorders
Emerging Pharmacological Treatments
Genetic Insights and Precision Medicine

Related conferences:

Related associations:

Related Societies:

Related Journals:

Neuroethics and Societal Impact

The Neuroethics and Societal Impact market is witnessing a growing prominence as ethical considerations in neuroscience research and technological advancements gain significance. This market analysis reflects an increasing awareness of the societal implications of neuroscientific discoveries. Stakeholders in neuroscience, healthcare, and technology sectors are navigating the ethical landscape, leading to the emergence of guidelines and frameworks. The market sees a demand for ethical decision-making tools, privacy safeguards in brain-related technologies, and public discourse platforms. Growing collaborations between ethicists, scientists, policymakers, and industry players shape the market. With an evolving emphasis on responsible innovation, the Neuroethics and Societal Impact market is poised for expansion, driven by the ethical considerations surrounding neuroscientific advancements and their far-reaching societal consequences.

Ethical Implications of Neurotechnology
Social Justice in neurological healthcare
Neuroscience and Moral Decision-Making

Related conferences:

Related associations:

Related Societies:

Related Journals:

Rehabilitation and Recovery

The Rehabilitation and Recovery market is experiencing notable growth as the global focus on comprehensive healthcare increases. The market analysis indicates a rising demand for Rehabilitation services and recovery solutions, driven by an aging population, a surge in chronic conditions, and advancements in medical technologies. Key segments include physical therapy, occupational therapy, and speech therapy, with a growing emphasis on home-based and telehealth Rehabilitation options. Technological innovations, such as virtual reality and wearable devices, are gaining traction in enhancing Rehabilitation outcomes. Geographically, North America dominates the market, followed by Europe and the Asia-Pacific region. Government initiatives, increased healthcare spending, and a shift towards value-based care contribute to market expansion. The market is characterized by competitive strategies, including mergers and acquisitions, partnerships, and product launches, as key players seek to capitalize on emerging opportunities in the Rehabilitation and Recovery sector.

Virtual Rehabilitation Technologies
Home-Based Rehabilitation Programs
Innovations in NeuroRehabilitation

Related conferences:

Related associations:

Related Societies:

Related Journals:

Emergency Medical Services (EMS) and Prehospital stroke Care

The Emergency Medical Services (EMS) and Prehospital stroke Care market are experiencing notable growth, driven by an increasing emphasis on prompt and specialized care for stroke patients. Market analysis highlights a surge in demand for advanced prehospital stroke care solutions, with a focus on efficient diagnosis and rapid initiation of treatment. The integration of telemedicine and mobile technologies in EMS systems enhances communication and enables early intervention. Additionally, the growing prevalence of strokes, coupled with aging populations, contributes to market expansion. Key players in the market are investing in the development of portable diagnostic tools and training programs for EMS personnel. Geographically, North America dominates the market, followed by Europe, attributed to well-established healthcare infrastructure. The Asia-Pacific region is witnessing significant growth, propelled by improving healthcare systems and increasing awareness of the importance of timely stroke care.

Technological Advances in Prehospital stroke Diagnosis
Training and Education for EMS Personnel
Global Disparities and Challenges in EMS stroke Response

Related conferences:

Related associations:

Related Societies:

Related Journals:

Acute stroke Management

The Acute stroke Management market is experiencing robust growth, fueled by advancements in stroke treatment protocols and a heightened emphasis on rapid intervention. Market analysis reveals a surge in demand for innovative technologies and pharmaceuticals aimed at improving patient outcomes during the acute phase of stroke. Thrombolytic agents, clot retrieval devices, and neuroprotective therapies are key contributors to market expansion. telemedicine solutions for stroke diagnosis and treatment planning are gaining traction, addressing the critical need for timely intervention. Geographically, North America and Europe dominate the market, driven by well-established healthcare infrastructure and increasing awareness. However, the Asia-Pacific region is witnessing rapid growth due to rising stroke incidences and improving access to healthcare. Key market players are investing in research and development, strategic collaborations, and product launches to maintain a competitive edge in this dynamic landscape.